P
Peter Aaby
Researcher at Bandim Health Project
Publications - 661
Citations - 31864
Peter Aaby is an academic researcher from Bandim Health Project. The author has contributed to research in topics: Population & Vaccination. The author has an hindex of 85, co-authored 640 publications receiving 28101 citations. Previous affiliations of Peter Aaby include Gentofte Hospital & University of Southern Denmark.
Papers
More filters
Journal ArticleDOI
Randomized Trials Comparing Inactivated Vaccine After Medium- or High-titer Measles Vaccine With Standard Titer Measles Vaccine After Inactivated Vaccine: A Meta-analysis.
Peter Aaby,Henrik Ravn,Christine Stabell Benn,Amabelia Rodrigues,Badara Samb,Salah A. Ibrahim,Michael Libman,Hilton Whittle +7 more
TL;DR: Mortality in girls was higher when they had received inactivated vaccines (after MTMV or HTMV) rather than live standard titer MV (after an inactivated vaccine) after 9 months of age.
Journal ArticleDOI
Long-term mortality after poliomyelitis.
TL;DR: Survivors of poliomyelitis, especially severely paralyzed polio patients, have an increased long-term mortality.
Journal ArticleDOI
Increased prevalence of HTLV-1 among HIV-2-infected women but not HIV-2-infected men in rural Guinea-Bissau.
Birgitta Holmgren,Sören Andersson,Elizabeth Harding,Maarten F. Schim van der Loeff,Pernille Vastrup,Peter Aaby,Koya Ariyoshi,Hilton Whittle +7 more
TL;DR: In women, the most important determinant of HTLV‐1 seropositivity was HIV‐2 infection, which may have implications in geographic areas where both types of retroviruses are prevalent.
Journal ArticleDOI
Stopping live vaccines after disease eradication may increase mortality
TL;DR: The imminent eradication of polio and the planned stop of OPV in 2024 and the subsequent eradications of measles infection and the possible stop to live MV could have negative effects for child survival.
Journal ArticleDOI
Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment.
Paulo Rabna,Andreas Andersen,Christian Wejse,Christian Wejse,Christian Wejse,Inés Oliveira,Victor F Gomes,Maya Bonde Haaland,Peter Aaby,Jesper Eugen-Olsen +9 more
TL;DR: Increased suPAR levels after one month of treatment was associated with increased risk of mortality during the remaining 7-month treatment period, and elevated suPAR level at time of initiation of TB treatment is confirmed.